Suppr超能文献

应对基于细胞的研究和干预措施相关隐私挑战的政策建议。

Policy recommendations for addressing privacy challenges associated with cell-based research and interventions.

作者信息

Ogbogu Ubaka, Burningham Sarah, Ollenberger Adam, Calder Kathryn, Du Li, El Emam Khaled, Hyde-Lay Robyn, Isasi Rosario, Joly Yann, Kerr Ian, Malin Bradley, McDonald Michael, Penney Steven, Piat Gayle, Roy Denis-Claude, Sugarman Jeremy, Vercauteren Suzanne, Verhenneman Griet, West Lori, Caulfield Timothy

机构信息

Faculties of Law and Pharmacy & Pharmaceutical Sciences, University of Alberta, 116 Street and 85 Avenue, Edmonton T6G 2R3, Canada.

出版信息

BMC Med Ethics. 2014 Feb 3;15:7. doi: 10.1186/1472-6939-15-7.

Abstract

BACKGROUND

The increased use of human biological material for cell-based research and clinical interventions poses risks to the privacy of patients and donors, including the possibility of re-identification of individuals from anonymized cell lines and associated genetic data. These risks will increase as technologies and databases used for re-identification become affordable and more sophisticated. Policies that require ongoing linkage of cell lines to donors' clinical information for research and regulatory purposes, and existing practices that limit research participants' ability to control what is done with their genetic data, amplify the privacy concerns.

DISCUSSION

To date, the privacy issues associated with cell-based research and interventions have not received much attention in the academic and policymaking contexts. This paper, arising out of a multi-disciplinary workshop, aims to rectify this by outlining the issues, proposing novel governance strategies and policy recommendations, and identifying areas where further evidence is required to make sound policy decisions. The authors of this paper take the position that existing rules and norms can be reasonably extended to address privacy risks in this context without compromising emerging developments in the research environment, and that exceptions from such rules should be justified using a case-by-case approach. In developing new policies, the broader framework of regulations governing cell-based research and related areas must be taken into account, as well as the views of impacted groups, including scientists, research participants and the general public.

SUMMARY

This paper outlines deliberations at a policy development workshop focusing on privacy challenges associated with cell-based research and interventions. The paper provides an overview of these challenges, followed by a discussion of key themes and recommendations that emerged from discussions at the workshop. The paper concludes that privacy risks associated with cell-based research and interventions should be addressed through evidence-based policy reforms that account for both well-established legal and ethical norms and current knowledge about actual or anticipated harms. The authors also call for research studies that identify and address gaps in understanding of privacy risks.

摘要

背景

用于基于细胞的研究和临床干预的人类生物材料使用的增加给患者和捐赠者的隐私带来了风险,包括从匿名细胞系和相关遗传数据中重新识别个人的可能性。随着用于重新识别的技术和数据库变得价格合理且更加精密复杂,这些风险将会增加。出于研究和监管目的要求将细胞系与捐赠者的临床信息持续关联的政策,以及限制研究参与者控制其遗传数据使用方式能力的现有做法,加剧了隐私方面的担忧。

讨论

迄今为止,与基于细胞的研究和干预相关的隐私问题在学术和政策制定背景下并未受到太多关注。本文源自一个多学科研讨会,旨在通过概述问题、提出新颖的治理策略和政策建议,以及确定做出合理政策决策所需进一步证据的领域来纠正这一情况。本文作者认为,现有规则和规范可以合理扩展以应对这种情况下的隐私风险,同时不损害研究环境中的新发展,并且此类规则的例外情况应采用逐案处理的方式进行论证。在制定新政策时,必须考虑到管理基于细胞的研究及相关领域的更广泛监管框架,以及受影响群体的观点,包括科学家、研究参与者和公众。

总结

本文概述了一次政策制定研讨会的审议情况,该研讨会聚焦于与基于细胞的研究和干预相关的隐私挑战。本文首先概述了这些挑战,随后讨论了研讨会讨论中出现的关键主题和建议。本文得出结论,与基于细胞的研究和干预相关的隐私风险应通过基于证据的政策改革来应对,这些改革既要考虑既定的法律和道德规范,也要考虑有关实际或预期危害的当前知识。作者们还呼吁开展研究,以识别和解决在隐私风险理解方面的差距。

相似文献

2
The future of Cochrane Neonatal.
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
3
Consent for governance in the ethical use of organoids.
Nat Cell Biol. 2018 Jun;20(6):642-645. doi: 10.1038/s41556-018-0112-5.
4
Policy forum. Data, privacy, and the greater good.
Science. 2015 Jul 17;349(6245):253-5. doi: 10.1126/science.aac4520. Epub 2015 Jul 16.
5
The Ethics of Big Data: Current and Foreseeable Issues in Biomedical Contexts.
Sci Eng Ethics. 2016 Apr;22(2):303-41. doi: 10.1007/s11948-015-9652-2. Epub 2015 May 23.
6
The effectiveness of health literacy interventions on the informed consent process of health care users: a systematic review protocol.
JBI Database System Rev Implement Rep. 2015 Oct;13(10):82-94. doi: 10.11124/jbisrir-2015-2304.
10

引用本文的文献

1
A double encryption protection algorithm for stem cell bank privacy data based on improved AES and chaotic encryption technology.
PLoS One. 2023 Oct 25;18(10):e0293418. doi: 10.1371/journal.pone.0293418. eCollection 2023.
2
The European General Data Protection Regulation: challenges and considerations for iPSC researchers and biobanks.
Regen Med. 2017 Sep;12(6):693-703. doi: 10.2217/rme-2017-0068. Epub 2017 Oct 4.
3
Genes, cells, and biobanks: Yes, there's still a consent problem.
PLoS Biol. 2017 Jul 25;15(7):e2002654. doi: 10.1371/journal.pbio.2002654. eCollection 2017 Jul.
4
The risk of re-identification versus the need to identify individuals in rare disease research.
Eur J Hum Genet. 2016 Nov;24(11):1553-1558. doi: 10.1038/ejhg.2016.52. Epub 2016 May 25.
5
Individualized medicine enabled by genomics in Saudi Arabia.
BMC Med Genomics. 2015;8 Suppl 1(Suppl 1):S3. doi: 10.1186/1755-8794-8-S1-S3. Epub 2015 Jan 15.

本文引用的文献

1
Human embryonic stem cells derived by somatic cell nuclear transfer.
Cell. 2013 Jun 6;153(6):1228-38. doi: 10.1016/j.cell.2013.05.006. Epub 2013 May 15.
2
NCI think tank concerning the identifiability of biospecimens and "omic" data.
Genet Med. 2013 Dec;15(12):997-1003. doi: 10.1038/gim.2013.40. Epub 2013 Apr 11.
3
Genomic data disclosure: time to reassess the realities.
Am J Bioeth. 2013;13(5):47-50. doi: 10.1080/15265161.2013.776134.
4
Cancer patient perceptions on the ethical and legal issues related to biobanking.
BMC Med Genomics. 2013 Mar 8;6:8. doi: 10.1186/1755-8794-6-8.
5
Stem cells: will they ever be the same?
Regen Med. 2013 Mar;8(2):97-9. doi: 10.2217/rme.13.9.
6
Data re-identification: societal safeguards.
Science. 2013 Mar 1;339(6123):1032-3. doi: 10.1126/science.339.6123.1032-c.
7
Genetic discrimination and life insurance: a systematic review of the evidence.
BMC Med. 2013 Jan 31;11:25. doi: 10.1186/1741-7015-11-25.
8
Identifying personal genomes by surname inference.
Science. 2013 Jan 18;339(6117):321-4. doi: 10.1126/science.1229566.
9
Research ethics. The complexities of genomic identifiability.
Science. 2013 Jan 18;339(6117):275-6. doi: 10.1126/science.1234593.
10
Trustworthy reuse of health data: a transnational perspective.
Int J Med Inform. 2013 Jan;82(1):1-9. doi: 10.1016/j.ijmedinf.2012.11.003. Epub 2012 Nov 20.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验